Latest News

FDA to step up oversight of cosmetics, assess ‘forever chemicals’


 

Interest from a U.S. senator

Dr. Peaslee was one of the authors of a 2021 article about PFAS in cosmetics that appeared in the journal Environmental Science and Technology Letters.

In the article, Dr. Peaslee and colleagues reported on their screening of 231 cosmetic products purchased in the United States and Canada using particle-induced gamma-ray emission spectroscopy. They found cases of undisclosed PFAS in cosmetic products. Foundations, mascaras, and lip products were noted as being especially problematic.

Sen. Susan Collins (R-ME) cited Dr. Peaslee’s article in a 2021 floor speech as she argued for having the FDA ban the intentional addition of PFAS to cosmetics.

“The findings of this study are particularly alarming, as many of these products are subject to direct human exposure,” Sen. Collins said. “For example, lipstick is often inadvertently ingested, and mascara is sometimes absorbed through tear ducts.”

In addition, workers at cosmetics plants may be exposed to PFAS and discarded cosmetics that have these compounds, which could potentially contaminate drinking water, Sen. Collins said. In 2021, she introduced legislation seeking a ban on PFAS that are intentionally added to cosmetics. That legislation did not advance through the Senate.

But the Senate Appropriations Committee, on which Sen. Collins is the ranking Republican, wants the FDA to keep a ban on PFAS in mind.

The Senate Agriculture Appropriations subcommittee, which oversees the FDA’s budget, raised the issue of PFAS and cosmetics in a June report. The FDA should develop a plan outlining research needed to inform “regulatory decision making, including potential development of a proposed rule to ban intentionally added PFAS substances in cosmetics,” the subcommittee said.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

What can you do during a mass shooting? This MD found out
MDedge Family Medicine
On the trail of a new vaccine for Lyme disease
MDedge Family Medicine
Low-dose oral minoxidil for female pattern hair loss: Benefits, impact on BP, heart rate evaluated
MDedge Family Medicine
Parental bias about a doctor can’t trump a patient’s health
MDedge Family Medicine
Dupilumab gains off-label uses as clinicians turn to drug for more indications
MDedge Family Medicine
Mothers in medicine: What can we learn when worlds collide?
MDedge Family Medicine
Risky drinking common in cancer survivors
MDedge Family Medicine
Answering the protein question when prescribing plant-based diets
MDedge Family Medicine
AAP’s hearing test clinical update is the first since 2009
MDedge Family Medicine
Cruel summer for medical students and Taylor Swift fans
MDedge Family Medicine